STOCKHOLDERS' EQUITY (Tables)

6 Months Ended

Aug. 31, 2019

Equity [Abstract]

Schedule of Stock-based Compensation Expense

Stock-based compensation expense is included in the following captions of the condensed consolidated statements of comprehensive income (loss) (in thousands):

	Three Months Ended				Six Months Ended
	August 31,				August 31,
	2019		2018		2019		2018
Cost of revenues	$	162	$	212	$	337	$	389
Research and development		633		420		1,046		785
Selling and marketing		982		680		1,651		1,251
General and administrative		1,406		1,368		2,692		2,722
	$	3,183	$	2,680	$	5,726	$	5,147

Summary of Stock Option Activity

Changes in our outstanding stock options during the six months ended August 31, 2019 were as follows (options in thousands):

	Number of Options			Weighted Average Exercise Price		Weighted average remaining contractual life (years)		Aggregate intrinsic value
Outstanding at February 28, 2019		1,054		$	13.44		5.8
Granted		171			11.11
Exercised		(83	)		2.36
Forfeited or expired		—			—
Outstanding at August 31, 2019		1,142		$	13.90		6.3	$	1,349
Exercisable at August 31, 2019		717		$	12.20		4.8	$	1,349

Summary of Restricted Stock Shares (RSU's), and Performance Stock Units (PSU's) Activity

Changes in our outstanding restricted stock shares, performance stock units (“PSUs”) and restricted stock units (“RSUs”) during the six months ended August 31, 2019 were as follows (restricted shares, PSUs and RSUs in thousands):

	Number of Restricted Shares, PSUs and RSUs			Weighted Average Grant Date Fair Value		Shares Retained to Cover Statutory Minimum Withholding Taxes
Outstanding at February 28, 2019		1,507		$	19.77
Granted		1,544			11.30
Vested		(441	)		18.91		150
Forfeited		(96	)		20.04
Outstanding at August 31, 2019		2,514		$	14.69